Citation Impact
Citing Papers
Preoperative CTLA-4 Blockade: Tolerability and Immune Monitoring in the Setting of a Presurgical Clinical Trial
2010 StandoutNobel
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
2017 StandoutNature
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
2010 Standout
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
2017 Standout
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2019 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners
2021
Effect of rapamycin on aging and age-related diseases—past and future
2020
The biology and management of non-small cell lung cancer
2018 StandoutNature
Hallmarks of aging: An expanding universe
2023 Standout
Systematic Review and Meta-analysis of Exercise Tolerance and Physical Functioning in Dialysis Patients Treated With Erythropoiesis-Stimulating Agents
2010
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
2016 StandoutNobel
Health-related quality of life outcomes in chronic kidney disease
2010
Acute Kidney Injury in Patients with Cancer
2017
Chronic kidney disease
2011 Standout
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 Standout
Acute kidney injury
2019 Standout
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Preliminary predictive criteria for COVID-19 cytokine storm
2020
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease
2010
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Association Between Hospital Staffing Models and Failure to Rescue
2018
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
2017 StandoutNobel
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Molecular and cellular insights into T cell exhaustion
2015 Standout
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
Health-related quality of life in different stages of chronic kidney disease and at initiation of dialysis treatment
2012
Chronic Kidney Disease
2016 Standout
Impact of Erythropoiesis-Stimulating Agents on Energy and Physical Function in Nondialysis CKD Patients With Anemia: A Systematic Review
2009
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
2011 Standout
Lung–Kidney Cross-Talk in the Critically Ill Patient
2016
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Computational design of a synthetic PD-1 agonist
2021 StandoutNobel
Establishment of NOD-Pdcd1-/-mice as an efficient animal model of type I diabetes
2005 StandoutNobel
HIF-1α is required for development of the sympathetic nervous system
2019 StandoutNobel
PD-1 Inhibits Antiviral Immunity at the Effector Phase in the Liver
2003 StandoutNobel
Facilitation of β Selection and Modification of Positive Selection in the Thymus of Pd-1–Deficient Mice
2000 StandoutNobel
Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model
2016 StandoutNobel
Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy
2014 StandoutNobel
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
2008 StandoutNobel
Cytokine Storm
2020 Standout
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Molecular Modeling and Functional Mapping of B7-H1 and B7-DC Uncouple Costimulatory Function from PD-1 Interaction
2003 StandoutNobel
Novel approaches to study coronary vasculature development in mice
2018
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells
2003 StandoutNobel
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine
2001 StandoutNobel
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
2016 StandoutNobel
Nephrotoxicity of anticancer treatment
2016
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
2017 Standout
Hydronephrosis associated with antiurothelial and antinuclear autoantibodies in BALB/c-Fcgr2b −/− Pdcd1 −/− mice
2005 StandoutNobel
Immune Checkpoint Blockade in Cancer Therapy
2015 Standout
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
PD-1 and Its Ligands in Tolerance and Immunity
2008 Standout
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
2002 StandoutNobel
Acute kidney injury in sepsis
2017
Works of David E. Leaf being referenced
Elevated FGF-23 in a patient with rhabdomyolysis-induced acute kidney injury
2009
Post-sepsis immunosuppression depends on NKT cell regulation of mTOR/IFN-γ in NK cells
2020
Increased plasma catalytic iron in patients may mediate acute kidney injury and death following cardiac surgery
2015
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors
2016
Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia
2008
Impact of Nonphysician Staffing on Outcomes in a Medical ICU
2011
A Genome-Wide Association Study to Identify Single-Nucleotide Polymorphisms for Acute Kidney Injury
2016
Connexin40 Imparts Conduction Heterogeneity to Atrial Tissue
2008
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection
2020